Abstract
Developing stable, biocompatible outer bio-encapsulations remains a critical challenge in establishing reliable, long-term neural interfaces that achieve peripheral nerve regeneration and prevent signal degradation without triggering host immune rejection. We evaluate the metabolic viability of various candidate hydrogels via in vitro integration of living cell cultures, identifying the most viable formulation as optimal. The novelty lies in the synergistic optimization of a biomimetic scaffold that serves simultaneously as a high-fidelity electrical interface and a regenerative matrix. Our hypothesis is that the integration of living cells within the optimal hydrogel matrix significantly mitigates the foreign body response (FBR) while maximizing axonal alignment and signal transduction efficiency. The study explores microfabrication techniques for biocompatible hydrogel structures using 3D bioprinting technology, which are essential for integrating electronic devices into the human body without triggering rejection reactions. Using the CellInk BioX bioprinter, cubic and tubular structures were fabricated and tested using various types of hydrogels: standard gelatin methacrylate (GelMA), GelMA_A, GelMA_C, and BioInk. The aim was to create a biocompatible protective encapsulation for an implantable chip. The study included complex in vitro experiments, testing materials by submersion in saline solutions (simulating human body fluids) and by inoculation with living cells (neurons), and comparing the effects of UV and ionic crosslinking treatments on structural stability and cell viability. The experiments revealed distinct material behaviors: BioInk and standard GelMA dissolved rapidly in the saline environment, becoming unsuitable for implant protection. Although GelMA_A demonstrated shape fidelity, it failed to support cellular life, reaching just a 10% viability rate. In contrast, the treated GelMA_C variant demonstrated superior results, as viability was significantly higher than the other materials, maintaining its structural integrity in the aqueous environment and ensuring a high cell viability rate of between 70% and 85%, values close to the control sample. The novelty of the work lies in the identification and experimental validation of the GelMA_C hydrogel as the optimal material that resolves the critical trade-off between the mechanical strength necessary to protect implantable electronics and the ability to actively support cellular regeneration. It was demonstrated that using GelMA_C, together with a specific crosslinking protocol, offers a stable and bio-friendly interface, superior to other commercial variants, paving the way for in vivo applications in regenerative bioelectronics.